← 產業報告目錄
India HbA1c Market Research Report Forecast to 2032
授權報價
| Single User Price | $2,950 USD |
| Multi User Licence (up to 10 users) | $3,950 USD |
| Enterprisewide Price (Global Site License) | $5,250 USD |
報告摘要
India HbA1c Market Research Report Forecast to 2032
Market Overview
India HbA1c Market is anticipated to register a CAGR of 8.49% during the review period. HbA1c testing is a blood test that measures the average level of blood sugar over the past two to three months. It is also known as glycated haemoglobin or A1C. This test is important for people with diabetes because it provides a more comprehensive view of blood sugar control than regular fingerstick tests, which only measure blood sugar levels at specific times.
The rising prevalence of type 2 diabetes and the increased prevalence of thalassemia and sickle cell disease coupled with growing awareness among Indians are major factors driving the growth of the India HbA1c testing market. However, the high cost of HbA1c testing due to technological advancements and frequent utilization of kits and reagents is expected to hamper the growth of the Indian market. Nevertheless, the growing geriatric population is anticipated to create lucrative opportunities for the players operating in the Indian market.
Market Segmentation
On the basis of product type, the India HbA1c testing market has been segmented into reagents & kits, instruments. Instruments were further segmented into bench top devices, and hand-held devices.
Based on technology, the market has been segmented into ion-exchange HPLC, immunoassay, boronate affinity HPLC, enzymatic assay, turbidimetric inhibition immunoassay (TINIA), and others.
Based on application, the market has been segmented into thalassemia, sickle cell anemia, and type 2 diabetes.
Based on end user, the market has been segmented into hospitals and clinics, diagnostic laboratories, and others.
Major Players
The key market players are Siemens Healthineers AG, Abbott, F. Hoffmann-La Roche Ltd, LumiraDx, Bio-Rad Laboratories, Inc., ARKRAY, Inc., Beckman Coulter Inc., LumiraDx, and Transasia Bio-Medicals.
目錄 Table of Contents
TABLE OF CONTENTS
13
1 MARKET INTRODUCTION 15
1.1 DEFINITION 15
1.2 SCOPE OF THE STUDY 15
1.3 RESEARCH OBJECTIVE 15
1.4 MARKET STRUCTURE 15
2 RESEARCH METHODOLOGY 16
2.1 OVERVIEW 16
2.2 DATA FLOW 18
2.2.1 Data Mining Process 18
2.3 PURCHASED DATABASE: 19
2.4 SECONDARY SOURCES: 20
2.4.1 Secondary Research data flow: 21
2.5 PRIMARY RESEARCH: 22
2.5.1 Primary Research DATA FLOW: 23
2.5.2 Primary Research: Number of Interviews conducted 24
2.6 APPROACHES FOR MARKET SIZE ESTIMATION: 24
2.6.1 Revenue Analysis Approach 24
2.7 DATA FORECASTING 25
2.7.1 Data forecasting Technique 25
2.8 DATA MODELLING 26
2.8.1 microeconomic factor analysis: 26
2.8.2 Data moldelling: 27
2.9 TEAMS AND ANALYST CONTRIBUTION 29
3 MARKET DYNAMICS 31
3.1 INTRODUCTION 31
3.2 DRIVERS 32
3.2.1 Rising Prevalence of Type 2 diabetes 32
3.2.2 Increased prevalence of Thalassemia and Sickle CELL among india 32
3.3 RESTRAINTS 33
3.3.1 High Cost of HbA1c Testing 33
3.4 OPPORTUNITY 34
3.4.1 Growing geriatric population 34
4 MARKET FACTOR ANALYSIS 35
4.1 PORTER'S FIVE FORCES MODEL 35
4.1.1 Threat of New Entrants 35
4.1.2 BARGAINING POWER OF SUPPLIERS 36
4.1.3 Threat of Substitutes 36
4.1.4 Bargaining Power of Buyers 36
4.1.5 Intensity of Rivalry 36
4.2 IMPACT OF COVID-19 ON THE INDIA HBA1C TESTING MARKET 37
4.3 REGULATORY LANDSCAPE BY INDIA 37
4.4 QUALITATIVE DATA ON NEW MEDTECH POLICES IN INDIA 38
4.5 OVERVIEW ON ISSUES EXPECTED FOR MAKE IN INDIA POLICES FORM TENDERS 39
4.6 CURRENT TRENDS IN THE INDIA HBA1C TESTING MARKET 40
4.7 QUALITATIVE DATA ON OPPORTUNITY FOR SELLING DIAGNOSTICS EQUIPMENTS FOR THE CLIENTS 42
5 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE 44
5.1 OVERVIEW 44
5.2 INSTRUMENTS 45
6 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY 47
6.1 OVERVIEW 47
7 INDIA HBA1C TESTING MARKET, BY APPLICATION 50
7.1 OVERVIEW 50
8 INDIA HBA1C TESTING MARKET, BY END USER 53
8.1 OVERVIEW 53
9 COMPETITIVE LANDSCAPE 57
9.1 INTRODUCTION 57
9.2 MARKET SHARE ANALYSIS, 2022 57
9.3 COMPETITOR DASHBOARD 58
9.4 PUBLIC PLAYERS STOCK SUMMARY 59
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 59
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 60
9.6.1 product launch 60
9.6.2 Collaboration 60
10 COMPANY PROFILES 61
10.1 SIEMENS HEALTHINEERS AG 61
10.1.1 COMPANY OVERVIEW 61
10.1.2 FINANCIAL OVERVIEW 62
10.1.3 productS OFFERED 62
10.1.4 KEY DEVELOPMENTS 62
10.1.5 SWOT ANALYSIS 63
10.1.6 KEY STRATEGIES 63
10.2 PTS DIAGNOSTICS 64
10.2.1 COMPANY OVERVIEW 64
10.2.2 FINANCIAL OVERVIEW 64
10.2.3 products OFFERED 65
10.2.4 KEY DEVELOPMENTS 65
10.2.5 KEY STRATEGIES 65
10.3 ARKRAY, INC 66
10.3.1 COMPANY OVERVIEW 66
10.3.2 FINANCIAL OVERVIEW 66
10.3.3 productS OFFERED 67
10.3.4 KEY DEVELOPMENTS 67
10.3.5 KEY STRATEGIES 67
10.4 F. HOFFMANN-LA ROCHE LTD 68
10.4.1 COMPANY OVERVIEW 68
10.4.2 FINANCIAL OVERVIEW 69
10.4.3 PRODUCTS OFFERED 69
10.4.4 KEY DEVELOPMENTS 69
10.4.5 SWOT ANALYSIS 70
10.4.6 KEY STRATEGIES 70
10.5 BECKMAN COULTER, INC. 71
10.5.1 COMPANY OVERVIEW 71
10.5.2 FINANCIAL OVERVIEW 71
10.5.3 Products OFFERed 71
10.5.4 KEY DEVELOPMENTS 71
10.5.5 SWOT ANALYSIS 72
10.5.6 KEY STRATEGIES 72
10.6 LUMIRADX 73
10.6.1 COMPANY OVERVIEW 73
10.6.2 FINANCIAL OVERVIEW 74
10.6.3 Products OFFERed 74
10.6.4 KEY DEVELOPMENTS 74
10.6.5 KEY STRATEGIES 74
10.7 ABBOTT 75
10.7.1 COMPANY OVERVIEW 75
10.7.2 FINANCIAL OVERVIEW 76
10.7.3 PRODUCTS OFFERED 76
10.7.4 KEY DEVELOPMENTS 77
10.7.5 SWOT ANALYSIS 77
10.7.6 KEY STRATEGIES 77
10.8 BIO-RAD LABORATORIES, INC. 78
10.8.1 COMPANY OVERVIEW 78
10.8.2 FINANCIAL OVERVIEW 79
10.8.3 PRODUCTS OFFERED 79
10.8.4 KEY DEVELOPMENTS 80
10.8.5 SWOT ANALYSIS 81
10.8.6 KEY STRATEGIES 81
10.9 TRANSASIA BIO-MEDICALS 82
10.9.1 COMPANY OVERVIEW 82
10.9.2 FINANCIAL OVERVIEW 82
10.9.3 PRODUCTS OFFERED 82
10.9.4 KEY DEVELOPMENTS 83
10.9.5 KEY STRATEGIES 83
10.10 HEMOCUE AB 84
10.10.1 COMPANY OVERVIEW 84
10.10.2 FINANCIAL OVERVIEW 84
10.10.3 Products OFFERed 84
10.10.4 KEY DEVELOPMENTS 84
10.10.5 KEY STRATEGIES 84
11 DATA CITATIONS 85
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MOLDELLING FOR MARKET SHARE ASSESSMENT 27
TABLE 2 REGULATORY LANDSCAPE BY INDIA 37
TABLE 3 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION) 45
TABLE 4 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2019–2032 (UNITS) 45
TABLE 5 INDIA HBA1C TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2019–2032 (USD MILLION) 45
TABLE 6 INDIA HBA1C TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2019–2032 (UNITS) 46
TABLE 7 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY, 2019–2032 (USD MILLION) 48
TABLE 8 INDIA HBA1C TESTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION) 51
TABLE 9 INDIA HBA1C TESTING MARKET, BY END USER, 2019–2032 (USD MILLION) 54
TABLE 10 INDIA HBA1C TESTING MARKET, FOR HOSPITALS, BY PRODUCT TYPE, 2019–2032 (UNITS) 54
TABLE 11 INDIA HBA1C TESTING MARKET, FOR GOVERNMENT HOSPITALS, BY PRODUCT TYPE, 2019–2032 (UNITS) 54
TABLE 12 INDIA HBA1C TESTING MARKET, FOR PRIVATE HOSPITALS, BY PRODUCT TYPE, 2019–2032 (UNITS) 55
TABLE 13 PUBLIC PLAYERS STOCK SUMMARY 59
TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 59
TABLE 15 PRODUCT LAUNCH 60
TABLE 16 COLLABORATION 60
TABLE 17 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED 62
TABLE 18 PTS DIAGNOSTICS: PRODUCT OFFERED 65
TABLE 19 PTS DIAGNOSTICS: KEY DEVELOPMENTS 65
TABLE 20 ARKRAY, INCPRODUCT OFFERED 67
TABLE 21 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 69
TABLE 22 BECKMAN COULTER INC.: PRODUCTS OFFERED 71
TABLE 23 LUMIRADX: PRODUCTS OFFERED 74
TABLE 24 ABBOTT: PRODUCTS OFFERED 76
TABLE 25 ABBOTT: KEY DEVELOPMENTS 77
TABLE 26 BIO-RAD LABORATORIES, INC.: PRODCUTS OFFERED 79
TABLE 27 TRANSASIA BIO-MEDICALS: PRODUCTS OFFERED 82
TABLE 28 HEMOCUE AB: PRODUCTS OFFERED 84
LIST OF FIGURES
FIGURE 1 INDIA HBA1C TESTING MARKET: STRUCTURE 15
FIGURE 2 INDIA HBA1C MARKET REPORT: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 31
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 33
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 34
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: INDIA HBA1C TESTING MARKET 35
FIGURE 6 INDIA HBA1C TESTING MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 44
FIGURE 7 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD MILLION) 45
FIGURE 8 INDIA HBA1C TESTING MARKET SHARE (%), BY PRODUCT TYPE, 2022 46
FIGURE 9 INDIA HBA1C TESTING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 47
FIGURE 10 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY, 2022 & 2032 (USD MILLION) 48
FIGURE 11 INDIA HBA1C TESTING MARKET SHARE (%), BY TECHNOLOGY, 2022 49
FIGURE 12 INDIA HBA1C TESTING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 50
FIGURE 13 INDIA HBA1C TESTING MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION) 51
FIGURE 14 INDIA HBA1C TESTING MARKET SHARE (%), BY APPLICATION, 2022 52
FIGURE 15 INDIA HBA1C TESTING MARKET, END USER SEGMENT ATTRACTIVENESS, 2022-2032 (USD MILLION) 53
FIGURE 16 INDIA HBA1C TESTING MARKET, BY END USER, 2022 & 2032 (USD MILLION) 53
FIGURE 17 INDIA HBA1C TESTING MARKET SHARE (%), BY END USER, 2022 55
FIGURE 18 INDIA HBA1C TESTING MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 57
FIGURE 19 COMPETITOR DASHBOARD: INDIA HBA1C TESTING MARKET 58
FIGURE 20 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT 62
FIGURE 21 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS 63
FIGURE 22 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 69
FIGURE 23 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 70
FIGURE 24 BECKMAN COULTER INC.: SWOT ANALYSIS 72
FIGURE 25 LUMIRADX: FINANCIAL OVERVIEW SNAPSHOT 74
FIGURE 26 ABBOTT: FINANCIAL OVERVIEW 76
FIGURE 27 ABBOTT: SWOT ANALYSIS 77
FIGURE 28 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW 79
FIGURE 29 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS 81
提及公司
Siemens Healthineers AGAbbottF. Hoffmann-La Roche LtdLumiraDxBio-Rad LaboratoriesInc.ARKRAYInc.Beckman Coulter Inc.LumiraDxand Transasia Bio-Medicals.
同分類最新報告（醫療與生命科學）
查看醫療與生命科學全部報告 →
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們